title: [Intra-arterial administration of Dalacin C phosphate (clindamycin) in the therapy of osteomyelitis of the jaws].
abstract: In 8 cases of maxillary and mandibular osteomyelitis which had failed to respond to traditional surgical and medicinal methods of treatment, a significant improvement could be achieved (in 7 of the 8 cases) by applying an intra-arterial clindamycin therapy. Treatment was carried out similar to the intra-arterial cytostatic perfusion treatment of tumors in the head and neck areas. Clindamycin was administered in daily dosages of 900 mg over a period of 8-23 days.
authors.affiliation: Semmelweis Orvostudományi Egyetem Szájsebészeti és Fogászati Klinika, Budapest.
authors.forename: V
authors.initials: V
authors.lastname: Gyenes
authors.forename: G
authors.initials: G
authors.lastname: Szabó
authors.forename: N
authors.initials: N
authors.lastname: Velich
mesh_terms: D000293:Adolescent; D000328:Adult; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial; D007571:Jaw Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010019:Osteomyelitis / Q000188:drug therapy*
chemical_list: D002981:Clindamycin